Atlas Trials

A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects

Clinical trial NCT04839926 · UNKNOWN

Trial details

NCT number
NCT04839926
Sponsor
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2021-03-02
Primary completion
2021-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.